Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

OBJECTIVE: To evaluate long-term clinical, functional and radiographic outcomes in an open-label extension (OLE) study in patients with rheumatoid arthritis (RA) receiving adalimumab monotherapy or adalimumab+methotrexate following attainment of low disease activity (LDA) with adalimumab+methotrexat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:RMD Open
Päätekijät: Keystone, Edward C, Breedveld, Ferdinand C, Kupper, Hartmut, Li, Yihan, Florentinus, Stefan, Sainsbury, Iain
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2018
Aiheet:
Rheumatoid Arthritis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018859/
https://ncbi.nlm.nih.gov/pubmed/29955381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000637
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia